929288-22-2 Usage
Uses
Used in Pharmaceutical Industry:
4-amino-2,6-dichloronicotinic acid is used as a reagent for the synthesis of pyrimidine-based scaffolds, which are essential structural components in the development of various pharmaceutical compounds. These scaffolds are found in a wide range of drugs, including antiviral, anticancer, and antimalarial medications, making 4-amino-2,6-dichloronicotinic acid a valuable asset in the creation of new and improved therapeutic agents.
Used in Chemical Research:
In addition to its applications in the pharmaceutical industry, 4-amino-2,6-dichloronicotinic acid is also utilized in chemical research for the development of novel compounds with potential applications in various fields. Its unique structure and reactivity make it a versatile building block for the synthesis of new molecules with diverse properties and functions.
Overall, 4-amino-2,6-dichloronicotinic acid is a significant compound in the fields of pharmaceuticals and chemical research, playing a crucial role in the synthesis of pyrimidine-based scaffolds and the development of new chemical entities with potential applications in medicine and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 929288-22-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,9,2,8 and 8 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 929288-22:
(8*9)+(7*2)+(6*9)+(5*2)+(4*8)+(3*8)+(2*2)+(1*2)=212
212 % 10 = 2
So 929288-22-2 is a valid CAS Registry Number.
929288-22-2Relevant articles and documents
Regioselective cross-coupling reactions and nucleophilic aromatic substitutions on a 5,7-dichloropyrido[4,3-d]pyrimidine scaffold
Jang, Mi-Yeon,Jonghe, Steven De,Gao, Ling-Jie,Herdewijn, Piet
, p. 8917 - 8920 (2006)
The synthesis of a 5,7-dichloropyrido[4,3-d]pyrimidine scaffold is described. The chlorine at position 5 can selectively be displaced by different palladium-catalyzed cross-coupling reactions and nucleophilic aromatic substitutions. In the subsequent step
HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS
-
Page/Page column 71-72, (2022/04/03)
The present invention provides heterocyclic compounds of formula (I), which are therapeutically useful as CBP/EP300 inhibitors. These compounds are useful in the treatment and/or prevention of diseases or disorders mediated by CBP and/or EP300 in an individual. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt, or a stereoisomer or a tautomer, an N-oxide or an ester thereof.
